IA
BLRX

IFP Advisors’s BioLineRX BLRX Stock Holding History

IFP Advisors’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed – – 2473
2018
Q4 		$0 Buy
+1
New +$481 ﹤0.01% 3535

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IFP Advisors's BLRX Position: Q1 2019 in Review

IFP Advisors sold out of BioLineRX (BLRX) in Q1 2019, closing a stake of 1 share.

IFP Advisors first reported a position in BLRX in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 31 funds tracked by Wall St. Rank hold BLRX as of Q1 2019.

  • IFP Advisors reported no remaining BioLineRX position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 1 BioLineRX share in Q1 2019.
  • IFP Advisors first reported a position in BioLineRX in Q4 2018 and held it in 1 quarter.
  • IFP Advisors's BioLineRX position peaked at $0 in Q4 2018.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.